Showing results (451-460 of 464) with videos related to

Sort By:
Pageof 47
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapseE L Sievers, R A Larson, E A Stadtmauer, et al.
Annals of Internal Medicine|April 1, 1983
Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblingsR Storb, R L Prentice, K M Sullivan, et al.
Leukemia Research|June 27, 2000
A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest oncology group study 9617T R Chauncey, C Rankin, J E Anderson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 1996
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recoveryK M Sullivan, J Storek, K J Kopecky, et al.
Bone Marrow Transplantation|June 1, 1996
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant diseaseK S Schiffman, W I Bensinger, F R Appelbaum, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant RegistryK M Sullivan, C Anasetti, M Horowitz, et al.
Bone Marrow Transplantation|August 28, 2003
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantationChien-Shing Chen, M Boeckh, K Seidel, et al.
Blood|October 26, 2000
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomasO W Press, J F Eary, T Gooley, et al.
Blood|January 1, 1996
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factorsJ E Anderson, F R Appelbaum, G Schoch, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 1, 1996
Barriers to bone marrow transplantation for sickle cell anemiaM C Walters, M Patience, W Leisenring, et al.
Pageof 47